✦ LIBER ✦

Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C

✍ Scribed by S. S. Tan; M. R. Abu Hassan; A. Abdullah; B. P. Ooi; T. Korompis; M. I. Merican

Book ID: 108886342
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 157 KB
Volume: 17
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2009.01191.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of pegylated-i

Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C

✍ OMER FARUK KOKOGLU; HASAN UÇMAK; SALIH HOSOGLU; ALI CETINKAYA; BULENT KANTARCEKE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

The safety of pegylated interferon alpha

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation

✍ M. van Zonneveld; H. J. Flink; E. Verhey; H. Senturk; S. Zeuzem; U. S. Akarca; Y 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Treatment of chronic hepatitis E in live

Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b

✍ Elizabeth B. Haagsma; Annelies Riezebos-Brilman; Arie P. van den Berg; Robert J. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

Hepatitis E virus (HEV) infections are known to run a self-limiting course. Recently, chronic hepatitis E has been described in immunosuppressed patients after solid-organ transplantation. Besides the general recommendation to lower the immunosuppressive medication in these patients, there is curren

Efficacy and safety of pegylated interfe

Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia

✍ R.-F. ZHANG; H.-Q. SUN; Q. HUANG; J.-R. WANG; X.-X. ZHANG; X.-N. LIU; Q. MA; H.- 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Efficacy and safety of peginterferon alp

Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C

✍ Richard Njouom; Michèle Tagni Sartre; Isabelle Timba; Eric Nerrienet; Patrice Tc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract Data were examined from a day‐to‐day clinical practice in Yaounde, Cameroon to evaluate the efficacy and safety of peginterferon alfa‐2a and ribavirin in treatment‐naive Cameroonian patients with chronic hepatitis C. Ninety adults with chronic hepatitis C (mean age, 53 ± 8 years; 79% ma

Interferon alfa-2b in combination with r

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics

✍ Regino P. González-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh